FDA-approved drug may finally help immunotherapy defeat rare liver cancer

A rare and aggressive form of liver cancer has long resisted immunotherapy, a treatment that helps the body's own immune system attack cancer cells. Now, researchers have identified a potential way to overcome that resistance using an FDA-approved drug that is already available for another medical condition.

1. Homepage
2. Science
3. FDA-approved drug may finally help immunotherapy defeat rare liver cancer